Tiziana Life Sciences Ltd (TLSA)

Currency in USD
2.200
+0.110(+5.26%)
Closed·
After Hours
2.230+0.030(+1.36%)
·
TLSA Scorecard
Full Analysis
Stock has taken a big hit over the last week
TLSA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0802.260
52 wk Range
0.6302.600
Key Statistics
Prev. Close
2.09
Open
2.09
Day's Range
2.08-2.26
52 wk Range
0.63-2.6
Volume
227.01K
Average Volume (3m)
338.13K
1-Year Change
49.29%
Book Value / Share
0.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLSA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.952
Upside
+261.48%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Tiziana Life Sciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Tiziana Life Sciences Ltd Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company’s lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn’s, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.

Compare TLSA to Peers and Sector

Metrics to compare
TLSA
Peers
Sector
Relationship
P/E Ratio
−20.4x−3.3x−0.5x
PEG Ratio
−0.59−0.060.00
Price/Book
61.6x2.5x2.6x
Price / LTM Sales
-20.1x3.3x
Upside (Analyst Target)
251.9%155.6%43.4%
Fair Value Upside
Unlock10.2%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.952
(+261.48% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TLSA Income Statement

People Also Watch

37.74
EXEL
+0.94%
18.23
SRPT
+1.50%
3.540
ONDS
+8.92%
5.29
REPL
-3.47%
2.010
IPA
+8.64%

FAQ

What Stock Exchange Does Tiziana Life Sciences Trade On?

Tiziana Life Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tiziana Life Sciences?

The stock symbol for Tiziana Life Sciences is "TLSA."

What Is the Tiziana Life Sciences Market Cap?

As of today, Tiziana Life Sciences market cap is 232.96M.

What Is Tiziana Life Sciences's Earnings Per Share (TTM)?

The Tiziana Life Sciences EPS (TTM) is -0.11.

From a Technical Analysis Perspective, Is TLSA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tiziana Life Sciences Stock Split?

Tiziana Life Sciences has split 1 times.

How Many Employees Does Tiziana Life Sciences Have?

Tiziana Life Sciences has 9 employees.

What is the current trading status of Tiziana Life Sciences (TLSA)?

As of 08 Aug 2025, Tiziana Life Sciences (TLSA) is trading at a price of 2.20, with a previous close of 2.09. The stock has fluctuated within a day range of 2.08 to 2.26, while its 52-week range spans from 0.63 to 2.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.